You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Global burden of early-onset pancreatic cancer attributable to metabolic risks from 1990 to 2021, and projections to 2030
- 2. B7-H7 knockdown suppresses the proliferation, metastasis, and drug resistance of B-cell non-Hodgkin lymphoma cells by inhibiting the PI3K/Akt pathway
- 3. Unexpected complete remission after recurrence in pancreatic cancer: a case report on comprehensive multimodal therapy
- 4. CARsgen Presents Preliminary Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 2025
- 5. Antengene Presents Latest ATG-022 Clinical Data at ESMO 2025 Demonstrating Efficacy Across All CLDN18.2 Expression Levels and Exceptional Tolerability
- 6. Diagnostic value of integrating salivary and blood miRNAs for pancreatic cancer detection
- 7. Boehringer's zongertinib demonstrated a 77% objective response rate in treatment-naïve patients with advanced HER2 (ERBB2)-mutant NSCLC
- 8. ESMO 2025: Chemo combination boosts overall survival in patients with EGFR-mutant NSCLC
- 9. NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025
- 10. Blocking a cellular switch could prevent lung-scarring disease
Last updated at 4:38 GMT
Hot News Makers
Health/Pharma Companies
-
41212.90
-
7982.46
-
4715.54
-
4099.96
-
3873.24
-
3584.29
-
2610.12
-
1887.17
-
1752.95
-
1748.21
Drugs, Treatments, Trials
-
8252.19
-
6601.40
-
4443.49
-
4293.90
-
3610.33
-
2428.70
-
1825.99
-
1792.81
-
740.11
-
398.63
Last updated at 4:10 GMT
